{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:53:45Z","timestamp":1791453225618,"version":"4.3.3"},"reference-count":92,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIH NIGMS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Vessels, Thrombosis & Hemostasis"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bvth.2026.100210","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:27:31Z","timestamp":1788388051000},"page":"100210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Endothelium-targeted and untargeted nanoparticle therapies in thromboinflammatory vascular diseases"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3417-6965","authenticated-orcid":false,"given":"Micheal O.","family":"Avoseh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5478-4611","authenticated-orcid":false,"given":"Hua","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0410-4563","authenticated-orcid":false,"given":"Oscar","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7613-2366","authenticated-orcid":false,"given":"Andrea T.","family":"Obi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter K.","family":"Henke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0886-2364","authenticated-orcid":false,"given":"Souvik","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Matthay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9251-357X","authenticated-orcid":false,"given":"Colin E.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.bvth.2026.100210_bib1","doi-asserted-by":"crossref","first-page":"15722","DOI":"10.3390\/ijms232415722","article-title":"Endothelial dysfunction and chronic inflammation: the cornerstones of vascular alterations in age-related diseases","volume":"23","author":"Pacinella","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.bvth.2026.100210_bib2","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1177\/0003319720987752","article-title":"Endothelial dysfunction and its clinical implications","volume":"72","author":"Poredos","year":"2021","journal-title":"Angiology"},{"issue":"8","key":"10.1016\/j.bvth.2026.100210_bib3","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/eurjpc\/zwab117","article-title":"Deep venous thrombosis and endothelial dysfunction in cancer: prevention and early initiated rehabilitation should be integral to a cardio-oncology programme","volume":"29","author":"Vrints","year":"2022","journal-title":"Eur J Prev Cardiol"},{"issue":"2","key":"10.1016\/j.bvth.2026.100210_bib4","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3390\/cells14020144","article-title":"The link between venous and arterial thrombosis: is there a role for endothelial dysfunction?","volume":"14","author":"Donadini","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.bvth.2026.100210_bib5","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jconrel.2021.03.034","article-title":"Atherosclerosis: conventional intake of cardiovascular drugs versus delivery using nanotechnology \u2013 a new chance for causative therapy?","volume":"333","author":"Groner","year":"2021","journal-title":"J Control Release"},{"issue":"23","key":"10.1016\/j.bvth.2026.100210_bib6","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1097\/CM9.0000000000003342","article-title":"Effect of endothelial responses on sepsis-associated organ dysfunction","volume":"137","author":"Wu","year":"2024","journal-title":"Chin Med J"},{"key":"10.1016\/j.bvth.2026.100210_bib7","doi-asserted-by":"crossref","first-page":"785220","DOI":"10.3389\/fphar.2021.785220","article-title":"Roles of macrophages in atherogenesis","volume":"12","author":"Farahi","year":"2021","journal-title":"Front Pharmacol"},{"issue":"6","key":"10.1016\/j.bvth.2026.100210_bib8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/pin.12921","article-title":"Pathophysiology of atherothrombosis: mechanisms of thrombus formation on disrupted atherosclerotic plaques","volume":"70","author":"Asada","year":"2020","journal-title":"Pathol Int"},{"key":"10.1016\/j.bvth.2026.100210_bib9","doi-asserted-by":"crossref","first-page":"846065","DOI":"10.3389\/fmedt.2022.846065","article-title":"Endothelial cell adhesion molecules- (un)attainable targets for nanomedicines","volume":"4","author":"Milo\u0161evi\u0107","year":"2022","journal-title":"Front Med Technology"},{"issue":"5","key":"10.1016\/j.bvth.2026.100210_bib10","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.ymthe.2024.03.004","article-title":"Targeting lipid nanoparticles to the blood-brain barrier to ameliorate acute ischemic stroke","volume":"32","author":"Nong","year":"2024","journal-title":"Mol Ther"},{"issue":"14","key":"10.1016\/j.bvth.2026.100210_bib11","doi-asserted-by":"crossref","first-page":"6223","DOI":"10.7150\/thno.73421","article-title":"Targeted delivery of nanomedicines for promoting vascular regeneration in ischemic diseases","volume":"12","author":"Zhuang","year":"2022","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/j.bvth.2026.100210_bib12","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1021\/bm3010484","article-title":"Influence of surface coating of PLGA particles on the internalization and functions of human endothelial cells","volume":"13","author":"Yu","year":"2012","journal-title":"Biomacromolecules"},{"issue":"1","key":"10.1016\/j.bvth.2026.100210_bib13","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1186\/s12951-024-02892-9","article-title":"Nanocarriers for targeted drug delivery in the vascular system: focus on endothelium","volume":"22","author":"Cong","year":"2024","journal-title":"J Nanobiotechnology"},{"issue":"7","key":"10.1016\/j.bvth.2026.100210_bib14","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1073\/pnas.1912012117","article-title":"Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood-brain barrier","volume":"117","author":"Marcos-Contreras","year":"2020","journal-title":"PNAS"},{"issue":"13","key":"10.1016\/j.bvth.2026.100210_bib15","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1093\/cvr\/cvaa047","article-title":"The choice of targets and ligands for site-specific delivery of nanomedicine to atherosclerosis","volume":"116","author":"Zia","year":"2020","journal-title":"Cardiovasc Res"},{"issue":"6","key":"10.1016\/j.bvth.2026.100210_bib16","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1172\/JCI29623","article-title":"Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo","volume":"117","author":"Ouedraogo","year":"2007","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.bvth.2026.100210_bib17","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/JLB.2MR0220-549R","article-title":"ICAM-1: A master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis","volume":"108","author":"Bui","year":"2020","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.bvth.2026.100210_bib18","article-title":"E-selectin-targeting delivery of microRNAs by microparticles ameliorates endothelial inflammation and atherosclerosis","volume":"6","author":"Ma","year":"2016","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.bvth.2026.100210_bib19","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.3390\/biomedicines12071504","article-title":"Targeted delivery of nanoparticles to blood vessels for the treatment of atherosclerosis","volume":"12","author":"Zong","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.bvth.2026.100210_bib20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.biomaterials.2017.08.045","article-title":"Co-coating of receptor-targeted drug nanocarriers with anti-phagocytic moieties enhances specific tissue uptake versus non-specific phagocytic clearance","volume":"147","author":"Kim","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.bvth.2026.100210_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jconrel.2019.05.021","article-title":"Unprecedently high targeting specificity toward lung ICAM-1 using 3DNA nanocarriers","volume":"305","author":"Roki","year":"2019","journal-title":"J Control Release"},{"issue":"42","key":"10.1016\/j.bvth.2026.100210_bib22","doi-asserted-by":"crossref","first-page":"16365","DOI":"10.1039\/C7NR06898K","article-title":"EGFR-targeting PLGA-PEG nanoparticles as a curcumin delivery system for breast cancer therapy","volume":"9","author":"Jin","year":"2017","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.bvth.2026.100210_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110196","article-title":"Robust genome editing in adult vascular endothelium by nanoparticle delivery of CRISPR-Cas9 plasmid DNA","volume":"38","author":"Zhang","year":"2022","journal-title":"Cell Rep"},{"issue":"43","key":"10.1016\/j.bvth.2026.100210_bib24","doi-asserted-by":"crossref","first-page":"e2004205","DOI":"10.1002\/smll.202004205","article-title":"Targeted delivery of cell softening micelles to Schlemm's canal endothelial cells for treatment of glaucoma","volume":"16","author":"Stack","year":"2020","journal-title":"Small"},{"key":"10.1016\/j.bvth.2026.100210_bib25","doi-asserted-by":"crossref","first-page":"105663","DOI":"10.1016\/j.jddst.2024.105663","article-title":"\u03b1v\u03b23 integrin targeting RGD peptide-based nanoparticles as an effective strategy for selective drug delivery to tumor microenvironment","volume":"96","author":"Kesharwani","year":"2024","journal-title":"J Drug Deliv Sci Technology"},{"issue":"11","key":"10.1016\/j.bvth.2026.100210_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/antiox13111339","article-title":"An RGD-conjugated prodrug nanoparticle with blood\u2013brain\u2013barrier penetrability for neuroprotection against cerebral ischemia\u2013reperfusion injury","volume":"13","author":"Taledaohan","year":"2024","journal-title":"Antioxidants"},{"issue":"2","key":"10.1016\/j.bvth.2026.100210_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10151","article-title":"Targeting functionalized nanoparticles to activated endothelial cells under high wall shear stress","volume":"5","author":"Zukerman","year":"2020","journal-title":"Bioeng Transl Med"},{"issue":"7","key":"10.1016\/j.bvth.2026.100210_bib28","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.3390\/nano10071353","article-title":"Endothelial cell targeting by crgd-functionalized polymeric nanoparticles under static and flow conditions","volume":"10","author":"Mart\u00ednez-Jothar","year":"2020","journal-title":"Nanomaterials"},{"issue":"2","key":"10.1016\/j.bvth.2026.100210_bib29","article-title":"VCAM-1-targeted gene delivery nanoparticles localize to inflamed endothelial cells and atherosclerotic plaques","volume":"4","author":"Distasio","year":"2021","journal-title":"Adv Ther (Weinh)"},{"key":"10.1016\/j.bvth.2026.100210_bib30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jconrel.2014.06.008","article-title":"Combination-targeting to multiple endothelial cell adhesion molecules modulates binding, endocytosis, and in vivo biodistribution of drug nanocarriers and their therapeutic cargoes","volume":"188","author":"Papademetriou","year":"2014","journal-title":"J Control Release"},{"issue":"pt 2","key":"10.1016\/j.bvth.2026.100210_bib31","doi-asserted-by":"crossref","first-page":"114147","DOI":"10.1016\/j.jconrel.2025.114147","article-title":"Vascular endothelial cell-targeted mRNA delivery via synthetic lipid nanoparticles for venous thrombosis prevention","volume":"388","author":"Guo","year":"2025","journal-title":"J Controlled Release"},{"issue":"26","key":"10.1016\/j.bvth.2026.100210_bib32","doi-asserted-by":"crossref","first-page":"2402445","DOI":"10.1002\/adma.202402445","article-title":"Revolutionizing neurocare: biomimetic nanodelivery via cell membranes","volume":"36","author":"Liao","year":"2024","journal-title":"Advanced Materials"},{"key":"10.1016\/j.bvth.2026.100210_bib33","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1039\/D5PM00044K","article-title":"Biomimetic nanoparticles for targeted therapy of liver disease","author":"Vijayan","year":"2025","journal-title":"RSC Pharmaceutics"},{"key":"10.1016\/j.bvth.2026.100210_bib34","doi-asserted-by":"crossref","first-page":"944518","DOI":"10.3389\/fbioe.2022.944518","article-title":"Research update on cell membrane camouflaged nanoparticles for cancer therapy","volume":"5","author":"Wang","year":"2022","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"issue":"9","key":"10.1016\/j.bvth.2026.100210_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/tcr.202400087","article-title":"Biomimetic nanoparticles for the diagnosis and therapy of atherosclerosis","volume":"24","author":"Wang","year":"2024","journal-title":"Chemical Record"},{"key":"10.1016\/j.bvth.2026.100210_bib36","doi-asserted-by":"crossref","first-page":"2300304","DOI":"10.1002\/adtp.202300304","article-title":"Biomedical applications of cell membrane-based biomimetic nano-delivery system","volume":"7","author":"Zhang","year":"2024","journal-title":"Advanced Therapeutics"},{"key":"10.1016\/j.bvth.2026.100210_bib37","article-title":"Biomimetic nano drug delivery carriers for treating cardiovascular diseases","volume":"33","author":"Zinger","year":"2021","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.bvth.2026.100210_bib38","doi-asserted-by":"crossref","first-page":"5726","DOI":"10.1038\/s41467-021-26052-x","article-title":"Cell membrane coating integrity affects the internalization mechanism of biomimetic nanoparticles","volume":"12","author":"Liu","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.bvth.2026.100210_bib39","doi-asserted-by":"crossref","first-page":"6181","DOI":"10.1038\/s41467-022-33889-3","article-title":"Systematic design of cell membrane coating to improve tumor targeting of nanoparticles","volume":"13","author":"Liu","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.bvth.2026.100210_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-03422-5","article-title":"Optimization of critical parameters for coating of polymeric nanoparticles with plasma membrane vesicles by sonication","volume":"11","author":"Yang","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.bvth.2026.100210_bib41","doi-asserted-by":"crossref","first-page":"e1919","DOI":"10.1002\/wnan.1919","article-title":"Nanotechnology translation in vascular diseases: from design to the bench","volume":"16","author":"Zhou","year":"2024","journal-title":"Wiley Interdiscip Rev Nanomedicine Nanobiotechnology"},{"issue":"1","key":"10.1016\/j.bvth.2026.100210_bib42","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-023-02040-9","article-title":"Biomimetic nanoparticles to enhance the reverse cholesterol transport for selectively inhibiting development into foam cell in atherosclerosis","volume":"21","author":"Zhu","year":"2023","journal-title":"J Nanobiotechnology"},{"issue":"pt A","key":"10.1016\/j.bvth.2026.100210_bib43","article-title":"Biomimetic nanoparticles of platelet membranes carrying bFGF and VEGFA genes promote deep burn wound healing","volume":"125","author":"Wang","year":"2023","journal-title":"Int Immunopharmacol"},{"issue":"35","key":"10.1016\/j.bvth.2026.100210_bib44","doi-asserted-by":"crossref","first-page":"e1902011","DOI":"10.1002\/smll.201902011","article-title":"Targeted drug delivery to stroke via chemotactic recruitment of nanoparticles coated with membrane of engineered neural stem cells","volume":"15","author":"Ma","year":"2019","journal-title":"Small"},{"key":"10.1016\/j.bvth.2026.100210_bib45","doi-asserted-by":"crossref","first-page":"136960","DOI":"10.1016\/j.cej.2022.136960","article-title":"Precisely co-delivery of protein and ROS scavenger with platesomes for enhanced endothelial barrier preservation against myocardial ischemia reperfusion injury","volume":"446","author":"Gao","year":"2022","journal-title":"Chem Eng J"},{"issue":"4","key":"10.1016\/j.bvth.2026.100210_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/jfb13040181","article-title":"Platelet membrane\u2013encapsulated MSNs loaded with SS31 peptide alleviate myocardial ischemia-reperfusion injury","volume":"13","author":"Zhang","year":"2022","journal-title":"J Funct Biomater"},{"key":"10.1016\/j.bvth.2026.100210_bib47","article-title":"Platelet membrane biomimetic nanoparticles combined with UTMD to improve the stability of atherosclerotic plaques","volume":"10","author":"Zhou","year":"2022","journal-title":"Front Chem"},{"issue":"8","key":"10.1016\/j.bvth.2026.100210_bib48","doi-asserted-by":"crossref","first-page":"7721","DOI":"10.1021\/acsnano.3c00288","article-title":"Neutrophil-membrane-coated biomineralized metal-organic framework nanoparticles for atherosclerosis treatment by targeting gene silencing","volume":"17","author":"Liu","year":"2023","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.bvth.2026.100210_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17060766","article-title":"Sivelestat-loaded neutrophil-membrane-coated antioxidative nanoparticles for targeted endothelial protection in sepsis","volume":"17","author":"Wei","year":"2025","journal-title":"Pharmaceutics"},{"issue":"37","key":"10.1016\/j.bvth.2026.100210_bib50","doi-asserted-by":"crossref","first-page":"49660","DOI":"10.1021\/acsami.4c11370","article-title":"Macrophage membrane spontaneously encapsulated cyclodextrin-based nanomedicines for improving lipid metabolism and inflammation in atherosclerosis","volume":"16","author":"Mou","year":"2024","journal-title":"ACS Appl Mater Inter"},{"issue":"37","key":"10.1016\/j.bvth.2026.100210_bib51","doi-asserted-by":"crossref","first-page":"43374","DOI":"10.1021\/acsami.3c07371","article-title":"Shear stress and ROS dual-responsive RBC-hitchhiking nanoparticles for atherosclerosis therapy","volume":"15","author":"Shen","year":"2023","journal-title":"ACS Appl Mater Inter"},{"issue":"2","key":"10.1016\/j.bvth.2026.100210_bib52","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.bvth.2026.100210_bib53","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J Nanobiotechnology"},{"issue":"17","key":"10.1016\/j.bvth.2026.100210_bib54","doi-asserted-by":"crossref","first-page":"7921","DOI":"10.7150\/thno.49577","article-title":"The EPR effect and beyond: strategies to improve tumor targeting and cancer nanomedicine treatment efficacy","volume":"10","author":"Shi","year":"2020","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.bvth.2026.100210_bib55","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41392-021-00631-2","article-title":"Recent progress in targeted delivery vectors based on biomimetic nanoparticles","volume":"6","author":"Patra","year":"2021","journal-title":"Signal Transduction Targeted Ther"},{"issue":"1","key":"10.1016\/j.bvth.2026.100210_bib56","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-022-01686-1","article-title":"Thrombus-specific\/responsive biomimetic nanomedicine for spatiotemporal thrombolysis and alleviation of myocardial ischemia\/reperfusion injury","volume":"20","author":"Guo","year":"2022","journal-title":"J Nanobiotechnology"},{"issue":"8","key":"10.1016\/j.bvth.2026.100210_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24087333","article-title":"Simultaneous inhibition of thrombosis and inflammation is beneficial in treating acute myocardial infarction","volume":"24","author":"Vargas","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"44","key":"10.1016\/j.bvth.2026.100210_bib58","doi-asserted-by":"crossref","first-page":"e2004172","DOI":"10.1002\/smll.202004172","article-title":"Active transportation of liposome enhances tumor accumulation, penetration, and therapeutic efficacy","volume":"16","author":"Wang","year":"2020","journal-title":"Small"},{"key":"10.1016\/j.bvth.2026.100210_bib59","doi-asserted-by":"crossref","first-page":"7092151","DOI":"10.1155\/2019\/7092151","article-title":"Vascular inflammation and oxidative stress: major triggers for cardiovascular disease","volume":"2019","author":"Steven","year":"2019","journal-title":"Oxidative Med Cell Longevity"},{"issue":"8","key":"10.1016\/j.bvth.2026.100210_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202311305","article-title":"Biomimetic targeting nanoplatform for atherosclerosis theranostics via photoacoustic diagnosis and \u201chand-in-hand\u201d immunoregulation","volume":"34","author":"Ma","year":"2024","journal-title":"Adv Funct Mater"},{"issue":"7","key":"10.1016\/j.bvth.2026.100210_bib61","doi-asserted-by":"crossref","first-page":"e2404319","DOI":"10.1002\/adhm.202404319","article-title":"Acid-triggered cascaded responsive supramolecular peptide alleviates myocardial ischemia\u2012reperfusion injury by restoring redox homeostasis and protecting mitochondrial function","volume":"14","author":"Liao","year":"2025","journal-title":"Adv Healthc Mater"},{"issue":"9","key":"10.1016\/j.bvth.2026.100210_bib62","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1021\/acs.nanolett.2c03784","article-title":"ROS-responsive nanoparticle delivery of mRNA and photosensitizer for combinatorial cancer therapy","volume":"23","author":"Zhou","year":"2023","journal-title":"Nano Lett"},{"issue":"25","key":"10.1016\/j.bvth.2026.100210_bib63","doi-asserted-by":"crossref","first-page":"e2501962","DOI":"10.1002\/adhm.202501962","article-title":"ROS-response nanoparticles for edaravone delivery: pathological-activated neuroprotection against ischemic-reperfusion injury in ischemic stroke","volume":"14","author":"Zhou","year":"2025","journal-title":"Adv Healthc Mater"},{"issue":"709","key":"10.1016\/j.bvth.2026.100210_bib64","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abm5755","article-title":"Endothelial FoxM1 reactivates aging-impaired endothelial regeneration for vascular repair and resolution of inflammatory lung injury","volume":"15","author":"Huang","year":"2023","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.bvth.2026.100210_bib65","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.125.326357","article-title":"The unexpected protective role of thrombosis in lung injury via endothelial Alox15","volume":"138","author":"Evans","year":"2026","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.bvth.2026.100210_bib66","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1164\/rccm.201906-1232OC","article-title":"Nanoparticle delivery of proangiogenic transcription factors into the neonatal circulation inhibits alveolar simplification caused by hyperoxia","volume":"202","author":"Bolte","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.bvth.2026.100210_bib67","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nnano.2014.84","article-title":"In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight","volume":"9","author":"Dahlman","year":"2014","journal-title":"Nat Nanotechnol"},{"issue":"8","key":"10.1016\/j.bvth.2026.100210_bib68","first-page":"274","article-title":"Advances in the stimuli-responsive mesoporous silica nanoparticles as drug delivery system nanotechnology for controlled release and cancer therapy. 3","volume":"13","author":"Zhu","year":"2023","journal-title":"Biotech"},{"key":"10.1016\/j.bvth.2026.100210_bib69","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jconrel.2023.02.037","article-title":"Targeted drug delivery to the brain endothelium dominates over passive delivery via vascular leak in experimental intracerebral hemorrhage","volume":"356","author":"Reyes-Esteves","year":"2023","journal-title":"J Control Release"},{"issue":"12","key":"10.1016\/j.bvth.2026.100210_bib70","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1021\/acs.accounts.3c00151","article-title":"Ligand chemistry in antitumor theranostic nanoparticles","volume":"56","author":"Lin","year":"2023","journal-title":"Acc Chem Res"},{"issue":"24","key":"10.1016\/j.bvth.2026.100210_bib71","doi-asserted-by":"crossref","first-page":"13302","DOI":"10.3390\/ijms252413302","article-title":"Nanoparticle strategies for treating CNS disorders: a comprehensive review of drug delivery and theranostic applications","volume":"25","author":"Toader","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.bvth.2026.100210_bib72","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.3390\/biomedicines13071720","article-title":"Targeted and biomimetic nanoparticles for atherosclerosis therapy: a review of emerging strategies","volume":"13","author":"Bartusik-Aebisher","year":"2025","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.bvth.2026.100210_bib73","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2147\/VHRM.S1653","article-title":"Clinical efficacy and safety of statins in managing cardiovascular risk","volume":"4","author":"Kapur","year":"2008","journal-title":"Vasc Health Risk Manag"},{"issue":"16","key":"10.1016\/j.bvth.2026.100210_bib74","doi-asserted-by":"crossref","first-page":"9433","DOI":"10.1039\/D1RA00074H","article-title":"Cytotoxicity of targeted PLGA nanoparticles: a systematic review","volume":"11","author":"Chiu","year":"2021","journal-title":"RSC Adv"},{"key":"10.1016\/j.bvth.2026.100210_bib75","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1146\/annurev-pharmtox-011613-140002","article-title":"Nanocarriers for vascular delivery of anti-inflammatory agents","volume":"54","author":"Howard","year":"2014","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.bvth.2026.100210_bib76","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.2147\/IJN.S64301","article-title":"Passing through the renal clearance barrier: toward ultrasmall sizes with stable ligands for potential clinical applications","volume":"9","author":"Zhang","year":"2014","journal-title":"Int J Nanomedicine"},{"issue":"6","key":"10.1016\/j.bvth.2026.100210_bib77","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.nano.2011.12.001","article-title":"Polystyrene nanoparticles affecting blood coagulation","volume":"8","author":"Oslakovic","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bvth.2026.100210_bib78","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","article-title":"Anti-PEG antibodies: properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals","volume":"154-155","author":"Kozma","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"issue":"pt A","key":"10.1016\/j.bvth.2026.100210_bib79","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"10.1016\/j.bvth.2026.100210_bib80","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jconrel.2006.08.017","article-title":"Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection","volume":"115","author":"Ishida","year":"2006","journal-title":"J Control Release"},{"issue":"11","key":"10.1016\/j.bvth.2026.100210_bib81","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.7150\/thno.22164","article-title":"Pre-existing anti-polyethylene glycol antibody reduces the therapeutic efficacy and pharmacokinetics of PEGylated liposomes","volume":"8","author":"Hsieh","year":"2018","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.bvth.2026.100210_bib82","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1016\/j.apsb.2023.05.024","article-title":"Pulmonary endothelium-targeted nanoassembly of indomethacin and superoxide dismutase relieves lung inflammation","volume":"13","author":"Yang","year":"2023","journal-title":"Acta Pharm Sin B"},{"issue":"11","key":"10.1016\/j.bvth.2026.100210_bib83","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.128833","article-title":"The ex vivo human lung: research value for translational science","volume":"4","author":"Ross","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.bvth.2026.100210_bib84","doi-asserted-by":"crossref","first-page":"110768","DOI":"10.1016\/j.msec.2020.110768","article-title":"Microfluidic-assisted polymer-protein assembly to fabricate homogeneous functionalnanoparticles","volume":"111","author":"Zhang","year":"2020","journal-title":"Mater Sci Eng C"},{"issue":"5","key":"10.1016\/j.bvth.2026.100210_bib85","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s13346-023-01477-7","article-title":"Freeze-drying revolution: unleashing the potential of lyophilization in advancing drug delivery systems","volume":"14","author":"Arora","year":"2024","journal-title":"Drug Deliv Transl Res"},{"issue":"10","key":"10.1016\/j.bvth.2026.100210_bib86","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14102044","article-title":"NIL10: a new IL10-receptor binding nanoparticle that induces cardiac protection in mice and pigs subjected to acute myocardial infarction through STAT3\/NF-\u03baB activation","volume":"14","author":"Tesoro","year":"2022","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.bvth.2026.100210_bib87","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3390\/pharmaceutics16101328","article-title":"Artificial intelligence (AI) applications in drug discovery and drug delivery: revolutionizing personalized medicine","volume":"16","author":"Serrano","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bvth.2026.100210_bib88","article-title":"Chemistry, Manufacturing, and Controls; Human Pharmacokinetics and Bioavailability; and Labeling Documentation","author":"Liposome Drug Products","year":"2018","journal-title":"US Food and Drug Administration"},{"issue":"6079","key":"10.1016\/j.bvth.2026.100210_bib89","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1126\/science.1205441","article-title":"FDA's approach to regulation of products of nanotechnology","volume":"336","author":"Hamburg","year":"2012","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.bvth.2026.100210_bib90","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/ATVBAHA.118.311569","article-title":"Nanoparticle therapy for vascular diseases","volume":"39","author":"Flores","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"10.1016\/j.bvth.2026.100210_bib91","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.7150\/thno.70896","article-title":"Inflammatory endothelium-targeted and cathepsin responsive nanoparticles are effective against atherosclerosis","volume":"12","author":"Fang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.bvth.2026.100210_bib92","doi-asserted-by":"crossref","DOI":"10.1177\/20417314241287487","article-title":"Intranasal delivery of macrophage cell membrane cloaked biomimetic drug-nanoparticle system attenuates acute lung injury","volume":"15","author":"Zhao","year":"2024","journal-title":"J Tissue Eng"}],"container-title":["Blood Vessels, Thrombosis & Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950327226000756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950327226000756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:29:00Z","timestamp":1791451740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950327226000756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":92,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2950327226000756"],"URL":"https:\/\/doi.org\/10.1016\/j.bvth.2026.100210","relation":{},"ISSN":["2950-3272"],"issn-type":[{"value":"2950-3272","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endothelium-targeted and untargeted nanoparticle therapies in thromboinflammatory vascular diseases","name":"articletitle","label":"Article Title"},{"value":"Blood Vessels, Thrombosis & Hemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bvth.2026.100210","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100210"}}